Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Go back to Fulcrum Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
(NASDAQ: FULC) Delayed: 3.74 --0 (-0%)
Previous Close $3.74    52 Week High $ 
Open $3.75    52 Week Low $ 
Day High $3.76    P/E N/A 
Day Low $3.71    EPS $ 
Volume 394,833